Both in Pharmaceuticals
Foghorn Therapeutics vs Minerva Neurosciences
Over the past year FHTX returned −51.7% and NERV returned −42.6%; their daily moves had a correlation of 0.18.
FHTX −51.7% NERV −42.6%Growth of $1, one year, split-adjusted
| Metric | FHTX | NERV |
|---|---|---|
| Price | $2.08 | $2.32 |
| Market cap | $123.5M | $110.8M |
| Today | −0.48% | +3.57% |
| 1 month | −28.8% | −28.2% |
| 6 months | −56.3% | −61.8% |
| Year to date | −61.5% | −42.3% |
| 1 year | −50.8% | −45.2% |
| Revenue growth (YoY) | +112.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −44.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.4× | — |
| Net cash | $167.6M | $75.3M |
| Dividend yield | — | — |
| Volatility (60d) | 101.3% | 80.2% |
| Short % of float | 7.3% | 6.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).